Clinical experience with the oxytocin challenge test

https://doi.org/10.1016/0002-9378(72)90279-7Get rights and content

Abstract

The oxytocin challenge test may provide information regarding fetal well-being which is helpful to the obstetrician. In this study, there were 65 negative tests on 43 patients, and those fetuses with negative tests uniformly did well, if there were no congenital anomalies or complications in the mechanics of delivery. There were 21 positive tests on 15 patients. A positive test was significant in that it confirmed the clinical impression that the fetus was existing in a markedly unfavorable environment, heralded a fall in maternal estriol excretion and, in 3 instances, signified impending intrauterine death. Loss of beat-to-beat variability of the fetal heart rate may increase the ominous prognosis of a positive test. In instances where the 24 hour urinary estriol excretion is chronically low and therefore of questionable value in timing delivery, the test provides a physiologic stress to the fetus, the response to which may reflect the degree of fetoplacental respiratory reserve. Or, when a positive oxytocin challenge test occurs in the face of normal 24 hour estriol production, the likelihood of subsequent fetal deterioration seems high.

References (10)

  • E.H. Hon et al.

    Am. J. Obstet. Gynecol

    (1960)
  • M.A. Schiffer et al.

    Am. J. Obstet. Gynecol

    (1970)
  • F.W. Kubli et al.
  • F.C. Greiss et al.

    Clin. Obstet. Gynecol

    (1968)
  • E.M. Ramsey

    Clin. Obstet. Gynecol

    (1968)
There are more references available in the full text version of this article.

Cited by (172)

  • No. 197a-Fetal Health Surveillance: Antepartum Consensus Guideline

    2018, Journal of Obstetrics and Gynaecology Canada
  • Fetal Assessment During Pregnancy

    2009, Pediatric Clinics of North America
    Citation Excerpt :

    Historically, the CST was the mainstay of fetal surveillance before the advent of other noninvasive tests. Developed in 1972 by Ray and colleagues,33 the CST was originally termed the “oxytocin challenge test.” During uterine contractions, placental blood flow is decreased.

  • Antenatal Testing: Diabetes Mellitus

    2008, Seminars in Perinatology
    Citation Excerpt :

    Based on the evaluation of the fetal heart rate response to uterine contractions, the CST has the potential to test for a chronic condition and serve as a surrogate for placental function. Ray and Freeman reported on the use of the CST in a cohort of diabetic women.5 Thirty-eight women had a weekly CST performed with the results blinded.

View all citing articles on Scopus
View full text